Becton Dickinson (BDX) Total Current Liabilities (2009 - 2026)
Becton Dickinson's (BDX) quarterly Total Current Liabilities came in at $9.4 billion in Q2 2026, up 15.25% year-over-year from $8.2 billion in Q2 2025, and up 10.54% quarter-over-quarter from $8.5 billion in Q1 2026.
Analysis
Becton Dickinson (BDX) Total Current Liabilities (2009 - 2026) Analysis & Trends
Becton Dickinson (BDX) has reported Total Current Liabilities for 18 consecutive years, with $9.4 billion the latest figure, recorded in Q2 2026.
- On a quarterly basis, Total Current Liabilities rose 15.25% year-over-year to $9.4 billion in Q2 2026; TTM through Jun 2026 was $9.4 billion, a 15.25% increase from a year earlier, with the FY2025 full-year figure at $8.3 billion, down 7.18% from the prior year.
- Total Current Liabilities was $9.4 billion for Q2 2026 at Becton Dickinson, up from $8.5 billion in the prior quarter.
- Over five years, Total Current Liabilities peaked at $9.4 billion in Q2 2026 and troughed at $6.6 billion in Q2 2024.
- A 5-year average of $7.7 billion and a median of $7.6 billion in 2022 frame the typical range for Total Current Liabilities.
- Across the five-year window, Total Current Liabilities retreated 14.98% in 2023 and surged 34.86% in 2024, its largest moves.
- Over 5 years, Total Current Liabilities stood at $7.6 billion in 2022, then decreased by 1.11% to $7.5 billion in 2023, then climbed by 1.64% to $7.7 billion in 2024, then climbed by 14.31% to $8.8 billion in 2025, then rose by 7.34% to $9.4 billion in 2026.
- The last three Total Current Liabilities figures came in at $9.4 billion (Q2 2026), $8.5 billion (Q1 2026), and $8.8 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 50.32 Bn | 49.46 Bn | 2.32 Bn | 9.40 Bn |
| 2 | Medline | 48.11 Bn | 52.93 Bn | 2.22 Bn | 2.71 Bn |
| 3 | West Pharmaceutical Services | 23.93 Bn | 23.49 Bn | 329.20 Mn | 640.50 Mn |
| 4 | Baxter International | 13.34 Bn | 11.16 Bn | 1.03 Bn | 3.59 Bn |
| 5 | Stevanato Group S.p.A | 6.21 Bn | 6.11 Bn | 100.91 Mn | - |
| 6 | Acme United | 241.34 Mn | 236.30 Mn | 26.69 Mn | 34.81 Mn |
| 7 | Rockwell Medical | 31.74 Mn | 6.94 Mn | 3.24 Mn | 11.17 Mn |
| 8 | Retractable Technologies | 21.26 Mn | -18.61 Mn | 190,852.00 | 13.37 Mn |
| 9 | United Health Products | 12.24 Mn | 12.21 Mn | - | 4.19 Mn |
| 10 | Cuprina Holdings (Cayman) | 8.09 Mn | 4.97 Mn | - | 3.12 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 9.40 Bn |
| Mar 31, 2026 | 8.51 Bn |
| Dec 31, 2025 | 8.76 Bn |
| Sep 30, 2025 | 8.31 Bn |
| Jun 30, 2025 | 8.16 Bn |
| Mar 31, 2025 | 7.69 Bn |
| Dec 31, 2024 | 7.66 Bn |
| Sep 30, 2024 | 8.96 Bn |
| Jun 30, 2024 | 6.61 Bn |
| Mar 31, 2024 | 7.33 Bn |
| Dec 31, 2023 | 7.54 Bn |
| Sep 30, 2023 | 6.64 Bn |
| Jun 30, 2023 | 6.88 Bn |
| Mar 31, 2023 | 7.30 Bn |
| Dec 31, 2022 | 7.63 Bn |
| Sep 30, 2022 | 7.81 Bn |
| Jun 30, 2022 | 7.08 Bn |
| Mar 31, 2022 | 6.66 Bn |
| Dec 31, 2021 | 6.74 Bn |
| Sep 30, 2021 | 6.63 Bn |